150 Dan Rd Ste 3
Canton, MA, 02021 United States
(781) 575-0198 †
Organogenesis has the skinny on replacement tissue. Its flagship product, Apligraf, is a human skin substitute approved to treat diabetic foot ulcers and venous leg ulcers caused by poor circulation. It has delivered more than 500,000 units of Apligraf for patient treatment. Rejection-resistant Apligraf is bio-engineered using living skin cells and has been used to treat chronic open wounds. Founded in 1985, the company is developing a next-generation of the material using all human components via its VCT technology. It also offers a line of biomaterials used in a range of surgical procedures to seal or reconstruct soft tissue and develops regenerative technologies in the area of cosmetic skin rejuvenation.
† Some telephone numbers on the Hoover’s site may be on a country’s do not call or do not contact list including, but not limited to, the United Kingdom’s CTPS or TPS registers. It is a legal requirement that companies do not make sales or marketing calls to registered numbers. These are central opt out registers whereby corporate subscribers and individuals can register their preference not to receive unsolicited sales and marketing telephone calls. By using the information provided on the Hoover’s sites, as the direct marketer you represent and warrant that you will use such information in compliance with all applicable local, state, national or international laws and regulations, including any local do not call registers or marketing regulations, and agree to defend, indemnify and hold harmless Dun & Bradstreet and each of its affiliates in the event your use violates such laws and regulations.